ASEAN’s Leading Radiopharmaceutical Company  

Exploring Partnership Pathways in Vietnam

Cyclotek is exploring opportunities to work with partners in Vietnam as interest in precision diagnostics, molecular imaging and advanced healthcare capability continues to grow across the region. Our role is to listen, collaborate and identify where Cyclotek's radiopharmaceutical manufacturing and development experience can support locally relevant needs over time. 

About Us

Experience Built Across Australia and New Zealand

Cyclotek brings experience across radiopharmaceutical manufacturing, clinical supply, CDMO support and research translation in Australia and New Zealand. In selected international markets, our approach is to work with local partners, respect local regulatory pathways and support sustainable capability development over time.

Established ANZ radiopharmaceutical manufacturing network
Supporting 200,000+ patient doses annually across Australia and New Zealand
Clinical, research and CDMO capability
Partnership-led regional growth
About Us

Supporting future access through collaboration

Vietnam is an important healthcare market in Southeast Asia, with growing interest in advanced diagnostics, oncology care and clinical capability. Cyclotek is taking a measured, relationship-led approach to understanding how its experience in radiopharmaceutical development, supply and clinical trial support may contribute to future capability in partnership with local organisations.

Our experienced team works collaboratively with hospitals, researchers and industry partners to deliver innovative radiopharmaceutical solutions that improve diagnosis, treatment and patient outcome. 

Products & Services

Capabilities that can support future access

Subject to local regulatory requirements and partnership models, Cyclotek can bring experience across radiopharmaceutical manufacturing, clinical trial support, technology transfer and time-critical supply chain planning.

PET Radiopharmaceuticals

A range of clinical, research and proprietary PET tracers.

Learn More

Product Supply & Logistics

Reliable radiopharmaceutical manufacturing and supply supporting clinical imaging and patient care across Australia and New Zealand.

Learn More

Contract Manufacturing

Advanced TGA and GMP licensed manufacturing facilities supporting commercial production, research and clinical trial supply.

Learn More
Local Collaboration 

A careful, partner-led pathway

Cyclotek is taking a thoughtful, partnership-led approach to exploring opportunities in Vietnam. By engaging with local stakeholders, we aim to understand how we can support future capability development, clinical research and patient access in ways that align with local needs and priorities.

Partnership & Research

Connecting capability, research and access

Speak with Cyclotek about partnership opportunities, clinical trial support, CDMO capability or future radiopharmaceutical access in Vietnam.

Partner with Cyclotek

Cyclotek works with healthcare providers, universities, research organisations and pharmaceutical partners to explore pathways that can connect scientific development with reliable manufacturing and patient access.


Contact Our Team
+61 3 9467 4966

Insights & Updates

Insights, Research & Industry Updates 

New Radiochemical Lab to Support Next-Gen Cancer Treatment


Learn More

National University of Singapore (NUS) Yong Loo Lin School of Medicine – Clinical Imaging Research Centre (CIRC) and Cyclotek Announce Strategic Collaboration to Strengthen Radiopharmaceutical Capability in Singapore and Across ASEAN


Learn More

CYCLOTEK’S NEW CEO SIGNALS EXPANSION INTO WESTERN AUSTRALIA


Learn More

Showing 3 / 50